ID CPLX2_HUMAN Reviewed; 134 AA. AC Q6PUV4; B2RAG2; O09056; Q13329; Q28184; Q52M15; Q64386; DT 16-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 16-AUG-2004, sequence version 2. DT 24-JAN-2024, entry version 142. DE RecName: Full=Complexin-2; DE AltName: Full=Complexin II; DE Short=CPX II; DE AltName: Full=Synaphin-1; GN Name=CPLX2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=7553862; DOI=10.1016/0092-8674(95)90239-2; RA McMahon H.T., Missler M., Li C., Suedhof T.C.; RT "Complexins: cytosolic proteins that regulate SNAP receptor function."; RL Cell 83:111-119(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Cerebellum; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-114, AND TISSUE SPECIFICITY. RC TISSUE=Cerebellum; RX PubMed=16162394; DOI=10.1016/j.gene.2005.07.005; RA Raevskaya N.M., Dergunova L.V., Vladychenskaya I.P., Stavchansky V.V., RA Oborina M.V., Poltaraus A.B., Limborska S.A.; RT "Structural organization of the human complexin 2 gene (CPLX2) and aspects RT of its functional activity."; RL Gene 359:127-137(2005). RN [5] RP TISSUE SPECIFICITY. RX PubMed=9853440; DOI=10.1016/s0140-6736(98)03341-8; RA Harrison P.J., Eastwood S.L.; RT "Preferential involvement of excitatory neurons in medial temporal lobe in RT schizophrenia."; RL Lancet 352:1669-1673(1998). RN [6] RP TISSUE SPECIFICITY. RX PubMed=11576753; DOI=10.1016/s0361-9230(01)00530-5; RA Eastwood S.L., Harrison P.J.; RT "Synaptic pathology in the anterior cingulate cortex in schizophrenia and RT mood disorders. A review and a Western blot study of synaptophysin, GAP-43 RT and the complexins."; RL Brain Res. Bull. 55:569-578(2001). RN [7] RP TISSUE SPECIFICITY. RX PubMed=11483314; DOI=10.1016/s0306-4522(01)00141-5; RA Eastwood S.L., Cotter D., Harrison P.J.; RT "Cerebellar synaptic protein expression in schizophrenia."; RL Neuroscience 105:219-229(2001). RN [8] RP TISSUE SPECIFICITY. RX PubMed=15906159; DOI=10.1007/s11068-004-0514-8; RA DiProspero N.A., Chen E.-Y., Charles V., Plomann M., Kordower J.H., RA Tagle D.A.; RT "Early changes in Huntington's disease patient brains involve alterations RT in cytoskeletal and synaptic elements."; RL J. Neurocytol. 33:517-533(2004). CC -!- FUNCTION: Negatively regulates the formation of synaptic vesicle CC clustering at active zone to the presynaptic membrane in postmitotic CC neurons. Positively regulates a late step in exocytosis of various CC cytoplasmic vesicles, such as synaptic vesicles and other secretory CC vesicles. Also involved in mast cell exocytosis (By similarity). CC {ECO:0000250|UniProtKB:P84086, ECO:0000250|UniProtKB:P84088}. CC -!- SUBUNIT: Binds to the SNARE core complex containing SNAP25, VAMP2 and CC STX1A. {ECO:0000250}. CC -!- INTERACTION: CC Q6PUV4; Q9HB07: MYG1; NbExp=3; IntAct=EBI-2689453, EBI-709754; CC Q6PUV4; Q9ULP0-2: NDRG4; NbExp=3; IntAct=EBI-2689453, EBI-11978907; CC Q6PUV4; Q96AL5: PBX3; NbExp=3; IntAct=EBI-2689453, EBI-741171; CC Q6PUV4; P43897: TSFM; NbExp=3; IntAct=EBI-2689453, EBI-1049298; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:P84087}. Presynapse CC {ECO:0000250|UniProtKB:P84087}. Nucleus {ECO:0000250|UniProtKB:P84087}. CC Perikaryon {ECO:0000250|UniProtKB:P84087}. Note=Translocated from the CC perikaryon to the presynaptic terminals during maturation of neuronal CC cells. In mast cells, cytosol and nucleus. Becomes enriched near plasma CC membrane following stimulation. {ECO:0000250|UniProtKB:P84087}. CC -!- TISSUE SPECIFICITY: Nervous system. In hippocampus and cerebellum, CC expressed mainly by excitatory neurons. Down-regulated in brain cortex CC from patients suffering from Huntington disease, bipolar disorder or CC major depression. Down-regulated in cerebellum from patients with CC schizophrenia. {ECO:0000269|PubMed:11483314, CC ECO:0000269|PubMed:11576753, ECO:0000269|PubMed:15906159, CC ECO:0000269|PubMed:16162394, ECO:0000269|PubMed:9853440}. CC -!- SIMILARITY: Belongs to the complexin/synaphin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U35100; AAC50229.1; -; mRNA. DR EMBL; AK314177; BAG36859.1; -; mRNA. DR EMBL; BC093706; AAH93706.1; -; mRNA. DR EMBL; BC112287; AAI12288.1; -; mRNA. DR EMBL; AY576870; AAS93622.1; -; mRNA. DR EMBL; BN000499; CAG26663.1; -; mRNA. DR EMBL; BN000500; CAG26664.1; -; mRNA. DR CCDS; CCDS4396.1; -. DR PIR; E57233; E57233. DR RefSeq; NP_001008221.1; NM_001008220.1. DR RefSeq; NP_006641.1; NM_006650.3. DR RefSeq; XP_005265855.1; XM_005265798.1. DR RefSeq; XP_005265856.1; XM_005265799.1. DR RefSeq; XP_011532721.1; XM_011534419.1. DR RefSeq; XP_016864453.1; XM_017008964.1. DR AlphaFoldDB; Q6PUV4; -. DR SMR; Q6PUV4; -. DR BioGRID; 116027; 24. DR CORUM; Q6PUV4; -. DR IntAct; Q6PUV4; 14. DR MINT; Q6PUV4; -. DR STRING; 9606.ENSP00000352544; -. DR iPTMnet; Q6PUV4; -. DR PhosphoSitePlus; Q6PUV4; -. DR BioMuta; CPLX2; -. DR DMDM; 51316998; -. DR jPOST; Q6PUV4; -. DR MassIVE; Q6PUV4; -. DR MaxQB; Q6PUV4; -. DR PaxDb; 9606-ENSP00000352544; -. DR PeptideAtlas; Q6PUV4; -. DR ProteomicsDB; 67260; -. DR TopDownProteomics; Q6PUV4; -. DR Antibodypedia; 45968; 201 antibodies from 26 providers. DR DNASU; 10814; -. DR Ensembl; ENST00000359546.8; ENSP00000352544.4; ENSG00000145920.15. DR Ensembl; ENST00000393745.8; ENSP00000377346.3; ENSG00000145920.15. DR Ensembl; ENST00000515094.1; ENSP00000421825.1; ENSG00000145920.15. DR GeneID; 10814; -. DR KEGG; hsa:10814; -. DR MANE-Select; ENST00000393745.8; ENSP00000377346.3; NM_001008220.2; NP_001008221.1. DR UCSC; uc003mde.2; human. DR AGR; HGNC:2310; -. DR CTD; 10814; -. DR DisGeNET; 10814; -. DR GeneCards; CPLX2; -. DR HGNC; HGNC:2310; CPLX2. DR HPA; ENSG00000145920; Group enriched (brain, epididymis). DR MIM; 605033; gene. DR neXtProt; NX_Q6PUV4; -. DR OpenTargets; ENSG00000145920; -. DR PharmGKB; PA26827; -. DR VEuPathDB; HostDB:ENSG00000145920; -. DR eggNOG; ENOG502RXXI; Eukaryota. DR GeneTree; ENSGT00950000182938; -. DR HOGENOM; CLU_132159_1_0_1; -. DR InParanoid; Q6PUV4; -. DR OMA; KHTRMEA; -. DR PhylomeDB; Q6PUV4; -. DR TreeFam; TF315172; -. DR PathwayCommons; Q6PUV4; -. DR SignaLink; Q6PUV4; -. DR BioGRID-ORCS; 10814; 21 hits in 1143 CRISPR screens. DR ChiTaRS; CPLX2; human. DR GeneWiki; CPLX2; -. DR GenomeRNAi; 10814; -. DR Pharos; Q6PUV4; Tbio. DR PRO; PR:Q6PUV4; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q6PUV4; Protein. DR Bgee; ENSG00000145920; Expressed in right hemisphere of cerebellum and 135 other cell types or tissues. DR ExpressionAtlas; Q6PUV4; baseline and differential. DR GO; GO:0044305; C:calyx of Held; IEA:Ensembl. DR GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell. DR GO; GO:0030425; C:dendrite; IEA:Ensembl. DR GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell. DR GO; GO:0098794; C:postsynapse; IEA:Ensembl. DR GO; GO:0031201; C:SNARE complex; IBA:GO_Central. DR GO; GO:0070033; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex; IEA:Ensembl. DR GO; GO:0070554; C:synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex; TAS:ParkinsonsUK-UCL. DR GO; GO:0043195; C:terminal bouton; IBA:GO_Central. DR GO; GO:0048306; F:calcium-dependent protein binding; IEA:Ensembl. DR GO; GO:0000149; F:SNARE binding; IBA:GO_Central. DR GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl. DR GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW. DR GO; GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW. DR GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW. DR GO; GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB. DR GO; GO:0017157; P:regulation of exocytosis; TAS:ParkinsonsUK-UCL. DR GO; GO:0046928; P:regulation of neurotransmitter secretion; IBA:GO_Central. DR GO; GO:0031630; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; IEA:Ensembl. DR GO; GO:0016079; P:synaptic vesicle exocytosis; IBA:GO_Central. DR GO; GO:0006904; P:vesicle docking involved in exocytosis; TAS:ProtInc. DR CDD; cd22808; Complexin_NTD_CPLX_I_II; 1. DR Gene3D; 1.20.5.580; Single Helix bin; 1. DR InterPro; IPR008849; Synaphin. DR PANTHER; PTHR16705; COMPLEXIN; 1. DR PANTHER; PTHR16705:SF9; COMPLEXIN-2; 1. DR Pfam; PF05835; Synaphin; 1. DR SUPFAM; SSF58038; SNARE fusion complex; 1. DR Genevisible; Q6PUV4; HS. PE 1: Evidence at protein level; KW Cell projection; Coiled coil; Cytoplasm; Differentiation; Exocytosis; KW Mast cell degranulation; Neurogenesis; Neurotransmitter transport; Nucleus; KW Phosphoprotein; Reference proteome; Synapse; Transport. FT CHAIN 1..134 FT /note="Complexin-2" FT /id="PRO_0000144875" FT REGION 1..114 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 41..97 FT /note="Interaction with the SNARE complex" FT /evidence="ECO:0000250" FT COILED 28..84 FT /evidence="ECO:0000255" FT COMPBIAS 18..86 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 93 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P84087" SQ SEQUENCE 134 AA; 15394 MW; 7791812FD4194AC5 CRC64; MDFVMKQALG GATKDMGKML GGEEEKDPDA QKKEEERQEA LRQQEEERKA KHARMEAERE KVRQQIRDKY GLKKKEEKEA EEKAALEQPC EGSLTRPKKA IPAGCGDEEE EEEESILDTV LKYLPGPLQD MFKK //